Dr Chloe Thompson-Peach

Dr Chloe Thompson-Peach was awarded a PhD in 2020 following her research into the identification of breast cancer susceptibility mutations in people who tested negative to having BRCA1 and BRCA2 gene mutations. The research addressed gaps in understanding the genetic predisposition to breast and ovarian cancer and identified new mutations in individuals which were previously undiagnosed. Dr Thompson-Peach’s research has since focussed on advancing precision medicine approaches for blood cancers at the South Australian Health and Medical Research Institute (SAHMRI), while also working as an academic at Flinders University to mentor future scientists.

Currently, Dr Thompson-Peach is researching new treatments for CALR-driven myelofibrosis—a rare blood cancer with limited effective treatment options. Her research aims to better understand why certain CALR mutations result in more severe symptoms and to create therapies which specifically target mutated cells while preserving the healthy ones. By tailoring treatments to different CALR mutations, Dr Thompson-Peach hopes to improve care and enhance outcomes for people with myelofibrosis.